Source: BMC Psychiatry. Unidade: FMRP
Subjects: PSIQUIATRIA, ONCOLOGIA, NEOPLASIAS, DEPRESSÃO, ANSIEDADE, ALUCINOGÊNICOS
ABNT
SANTOS, Rafael Guimarães dos e BOUSO, José Carlos e HALLAK, Jaime Eduardo Cecilio. Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer. BMC Psychiatry, v. 19, p. art. 321 [4] , 2019Tradução . . Disponível em: https://doi.org/10.1186/s12888-019-2288-z. Acesso em: 03 nov. 2024.APA
Santos, R. G. dos, Bouso, J. C., & Hallak, J. E. C. (2019). Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer. BMC Psychiatry, 19, art. 321 [4] . doi:10.1186/s12888-019-2288-zNLM
Santos RG dos, Bouso JC, Hallak JEC. Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer [Internet]. BMC Psychiatry. 2019 ; 19 art. 321 [4] .[citado 2024 nov. 03 ] Available from: https://doi.org/10.1186/s12888-019-2288-zVancouver
Santos RG dos, Bouso JC, Hallak JEC. Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer [Internet]. BMC Psychiatry. 2019 ; 19 art. 321 [4] .[citado 2024 nov. 03 ] Available from: https://doi.org/10.1186/s12888-019-2288-z